Team:SDU-Denmark
From 2012.igem.org
(17 intermediate revisions not shown) | |||
Line 249: | Line 249: | ||
<a href="https://2012.igem.org/Team:SDU-Denmark/Project/Overview" title=""><img src="https://static.igem.org/mediawiki/2012/9/95/Projectcqts2.gif" alt="" title="Project" class="picto" id=""></img></a> | <a href="https://2012.igem.org/Team:SDU-Denmark/Project/Overview" title=""><img src="https://static.igem.org/mediawiki/2012/9/95/Projectcqts2.gif" alt="" title="Project" class="picto" id=""></img></a> | ||
<a href="https://2012.igem.org/Team:SDU-Denmark/Project/BioBricks" title=""><img src="https://static.igem.org/mediawiki/2012/9/9a/BioBricks.gif" alt="" title="BioBricks" class="picto" id=""></img></a> | <a href="https://2012.igem.org/Team:SDU-Denmark/Project/BioBricks" title=""><img src="https://static.igem.org/mediawiki/2012/9/9a/BioBricks.gif" alt="" title="BioBricks" class="picto" id=""></img></a> | ||
- | <a href=" | + | <a href="https://2012.igem.org/Team:SDU-Denmark/labwork/Testing" title="Testing"><img src="https://static.igem.org/mediawiki/2012/3/32/Resultsqts.gif" alt="" title="Testing" class="picto"id="" ></img></a> |
- | <a href="https://2012.igem.org/Team:SDU-Denmark/Ethics/ | + | <a href="https://2012.igem.org/Team:SDU-Denmark/Ethics/Introduction" title=""><img src="https://static.igem.org/mediawiki/2012/1/19/Ethicsqbs.gif" alt="" title="Ethics" class="picto" id="" ></img></a> |
- | <a href="https://2012.igem.org/Team:SDU-Denmark/collaboration/ | + | <a href="https://2012.igem.org/Team:SDU-Denmark/collaboration/Overview" title=""><img src="https://static.igem.org/mediawiki/2012/5/5a/Sponsorsqts.gif" alt="" title="Collaboration" class="picto" id=""></img></a> |
<a href="https://2012.igem.org/Team:SDU-Denmark/Project/Achievements" title=""><img src="https://static.igem.org/mediawiki/2012/0/07/Pokal.gif" alt="" title="Achievements" class="picto" id=""></img></a> | <a href="https://2012.igem.org/Team:SDU-Denmark/Project/Achievements" title=""><img src="https://static.igem.org/mediawiki/2012/0/07/Pokal.gif" alt="" title="Achievements" class="picto" id=""></img></a> | ||
Line 262: | Line 262: | ||
<h1>Sucrose Limitation and Inulin Metabolism</h1> | <h1>Sucrose Limitation and Inulin Metabolism</h1> | ||
- | |||
- | |||
<h2> Abstract</h2> | <h2> Abstract</h2> | ||
<p> | <p> | ||
- | Obesity is associated with a low-grade inflammatory response, which among other things, is triggered by bacterial plasma lipopolysaccharide (LPS). A high-energy diet, increases the amount of LPS-producing gut microbiota, and increased LPS levels has been observed in obese individuals. By inducing changes in the gut microbiota by prebiotics, like inulin, it is possible to decrease the plasma LPS level. This is associated with the stimulation of bifidobacterial growth. We have designed a novel approach to address this issue of plasma LPS, by probioticly induce changes in the gut flora by genetically modifying a bacteria to produce plant originated inulin. We cloned the two genes encoding sucrose:sucrose fructosyltransferase (SST) and | + | Obesity is associated with a low-grade inflammatory response, which among other things, is triggered by bacterial plasma lipopolysaccharide (LPS). A high-energy diet, increases the amount of LPS-producing gut microbiota, and increased LPS levels has been observed in obese individuals. By inducing changes in the gut microbiota by prebiotics, like inulin, it is possible to decrease the plasma LPS level. This is associated with the stimulation of bifidobacterial growth. We have designed a novel approach to address this issue of plasma LPS, by probioticly induce changes in the gut flora by genetically modifying a bacteria to produce plant originated inulin. We cloned the two genes encoding sucrose:sucrose fructosyltransferase (SST) and fructan:fructan fructosyltransferase (FFT) from the Jerusalem artichoke into a E. coli, where it will produce inulin by using sucrose as an acceptor molecules. In the future this construct should be introduced by a probiotic lactobacillus, into the gut. |
</p> | </p> | ||
<center><img src="https://static.igem.org/mediawiki/2012/6/6f/IGEM_033.gif" width="100%" /></center> | <center><img src="https://static.igem.org/mediawiki/2012/6/6f/IGEM_033.gif" width="100%" /></center> | ||
+ | <br/><br/> | ||
+ | <h2>The story</h2> | ||
+ | <p> | ||
+ | <i>The team consists entirely of undergraduates and we started out with almost no experience in lab – Most of our supervisors were on vacation for the first part of our lab time, so we started from square one.<br/><br/> | ||
+ | We have chosen to focus on the outreach and documentation section. Therefore, we have loads of videos, interviews and photos. <br/><br/> | ||
+ | |||
+ | Research includes many more aspects than most people expect. The wet lab is extremely important, but many teams miss an important part of what iGEM is also about - spreading the message. | ||
+ | We, at SDU, see ourselves as pioneers in the field of Human Practices. It is a theme of great concern for the SDU iGEM Team. Therefore we have decided to make a big effort in many different areas. <br/> | ||
+ | We've gained a lot of PR coverage, had extensive outreach, made cooperation across Germany, Scandinavia and Canada amongst others. Furthermore, we have processed philosophical thoughts about our role in society as researchers. As a novelty, in iGEM auspices, we have included marketing and law, into our project as a focal point for our project.</i></p> | ||
</br></br> | </br></br> | ||
- | <h2>Not a | + | <h2>Not a Scientist? Here we Present the Translated Version of our Abstract</h2> |
<p> | <p> | ||
Obesity and its related disorders are a worldwide problem that fx costs america billions of dollars each year. | Obesity and its related disorders are a worldwide problem that fx costs america billions of dollars each year. |
Latest revision as of 22:11, 8 October 2012
Sucrose Limitation and Inulin Metabolism
Abstract
Obesity is associated with a low-grade inflammatory response, which among other things, is triggered by bacterial plasma lipopolysaccharide (LPS). A high-energy diet, increases the amount of LPS-producing gut microbiota, and increased LPS levels has been observed in obese individuals. By inducing changes in the gut microbiota by prebiotics, like inulin, it is possible to decrease the plasma LPS level. This is associated with the stimulation of bifidobacterial growth. We have designed a novel approach to address this issue of plasma LPS, by probioticly induce changes in the gut flora by genetically modifying a bacteria to produce plant originated inulin. We cloned the two genes encoding sucrose:sucrose fructosyltransferase (SST) and fructan:fructan fructosyltransferase (FFT) from the Jerusalem artichoke into a E. coli, where it will produce inulin by using sucrose as an acceptor molecules. In the future this construct should be introduced by a probiotic lactobacillus, into the gut.
The story
The team consists entirely of undergraduates and we started out with almost no experience in lab – Most of our supervisors were on vacation for the first part of our lab time, so we started from square one.
We have chosen to focus on the outreach and documentation section. Therefore, we have loads of videos, interviews and photos.
Research includes many more aspects than most people expect. The wet lab is extremely important, but many teams miss an important part of what iGEM is also about - spreading the message.
We, at SDU, see ourselves as pioneers in the field of Human Practices. It is a theme of great concern for the SDU iGEM Team. Therefore we have decided to make a big effort in many different areas.
We've gained a lot of PR coverage, had extensive outreach, made cooperation across Germany, Scandinavia and Canada amongst others. Furthermore, we have processed philosophical thoughts about our role in society as researchers. As a novelty, in iGEM auspices, we have included marketing and law, into our project as a focal point for our project.
Not a Scientist? Here we Present the Translated Version of our Abstract
Obesity and its related disorders are a worldwide problem that fx costs america billions of dollars each year. Literature suggests that a high-energy diet is the reason for obesity, not only because the body is unable to use all the energy, but in fact because the “bad” bacteria in your gut feeds on it. The jerusalem artichoke produces a sugar fiber called inulin, which apart from being non-digestible to humans, helps the good bacteria in the gut to grow and is beneficial in the prevention of colon cancer. From this information we decided to produce a beneficial (probiotic) bacteria that can convert table sugar (sucrose) into this inulin fiber. If we are successful in introducing this bacteria to the human gut, we can apply many beneficial aspects relating to obesity, such as decreased hunger, fat mass, body weight, inflammations and increased satisfaction from eating.
Featured video
This short documentary is all about the ethical aspects of dealing and working with genetically modified organisms(GMO)
Watch more videos in our video gallery